Reuters: Hot Stocks: BRIEF-BioMarin Pharma jumps in premarket after genetic disorder drug meets main goal

Reuters: Hot Stocks Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

BRIEF-BioMarin Pharma jumps in premarket after genetic disorder drug meets main goal Nov 5th 2012, 13:24 NEW YORK | Mon Nov 5, 2012 8:24am EST NEW YORK Nov 5 (Reuters) - BioMarin Pharmaceutical Inc : * BioMarin Pharma jumps 27.9 percent to $47.84 in premarket after genetic disorder drug meets main goal in late-stage trial

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions